Leaderboard

En | De
No articles selected!     View Cart  
You are here: Gastroenterology » Pankreas » Neoplasms 03. July 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Esophagus
Pankreas
Neoplasms
Pancreatitis
Others
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3036  Previews Next
   
   Articles 1 - 20 / 60719  
   
Emerging role of proteomics in advancing diagnosis, prognosis, and treatment of liver cancer.
Liver Res
Xu Y, Li J, Luo X, Xiang Z, Yang Z, Wei X, Xu X, Chen J.
PMID: 42395637 [PubMed - in process]


The National Clinical Database Risk Calculator and the 5-Item Modified Frailty Index Predict the Development of Postoperative Delirium After Surgery for Hepatocellular Carcinoma.
Ann Gastroenterol Surg
Hosoda K, Shimizu A, Kubota K, Notake T, Sakai H, Yoshikawa K, Ikehara T, Hayashi H, Yasukawa K, Soejima Y.
PMID: 42395150 [PubMed]


Differential Prognostic Impact of Prior Cholecystectomy Between Proximal and Distal Colorectal Cancer: A 12-Year Retrospective Cohort Study of 3487 Consecutive Patients.
Ann Gastroenterol Surg
Tsunematsu M, Haruki K, Yanamoto K, Takehana T, Ishizaki S, Yanagaki M, Shirai Y, Furukawa K, Onda S, Ikegami T.
PMID: 42395139 [PubMed - in process]


Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion Surgery.
Ann Gastroenterol Surg
Kosaka H, Kinoshita M, Yasuda S, Kakizaki S, Sugimoto R, Sakata J, Yamai K, Hatanaka T, Yamamoto Y, Sato T, Ishikawa T, Morikawa T, Hanaoka J, Mori H, Toyoda H, Sanuki T, Yokoi M, Shibata H, Fukuda K, Kawata K, Amaya K, Ito T, Hidaka M, Naganuma A, Sugimachi K, Toshiyama S, Yamasaki M, Kaibori M.
PMID: 42395119 [PubMed]


Surgical Outcomes and Recurrence Management in Borderline Resectable Hepatocellular Carcinoma: Implications for Multidisciplinary Strategies.
Ann Gastroenterol Surg
Haruki K, Furukawa K, Akaoka M, Yamahata Y, Onda S, Shirai Y, Tsunematsu M, Taniai T, Matsumoto M, Ikegami T.
PMID: 42395111 [PubMed - in process]


The role of quantitative contrast-enhanced endoscopic ultrasound in the differential diagnosis of pancreatic solid neoplasms: a proof-of-concept prospective study shifting from subjective to objective.
IGIE
Tacelli M, Bina N, Petrone MC, Zaccari P, Capurso G, Rossi G, Arcidiacono PG.
PMID: 42394870 [PubMed]


Radiomics-Based AI for the Diagnosis and Prognosis of Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis.
J Med Internet Res
Hua X, Fu R, Yin Z.
PMID: 42394422 [PubMed - indexed for MEDLINE]


Biomarkers in Liver Transplantation for Hepatocellular Carcinoma: Towards Precision Medicine.
Aliment Pharmacol Ther
Ma Y, Li H, Chen H, Xu J, Ye Z, Li Y, Wu X, Chen J, Cao C, Zhang P, Zhao R, Li J, Zhu C, Zhuo J, Xu S, Xu X, Lu D.
PMID: 42394399 [PubMed - as supplied by publisher]


Leveraging multimodal cancer immunotherapy to amplify the efficacy of oncolytic viruses.
Exp Hematol Oncol
Cai Q, Zhang L, Kong L, Fang J, Xu J, Gu X, Li W, Jiang C, Wu J.
PMID: 42393779 [PubMed - as supplied by publisher]


Effects of Immersive Virtual Reality Interventions on Symptom Management in Patients With Gastrointestinal Cancer: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
J Med Internet Res
Chen F, Guo X, Wang R, Li Y, Xu D, Wang Y, Kong W, Chen Y, Jin L, Xian X.
PMID: 42391636 [PubMed - indexed for MEDLINE]


Early Pancreatic Cancer: Clinical Implications, Workup, and Imaging Findings with Histopathologic Correlation for Personalized Surveillance.
Radiographics
Kano S, Gonoi W, Nakaya M, Inui S, Nakai Y, Masuoka S, Masumoto T, Minami M, Gaballah AH, Abe O.
PMID: 42391031 [PubMed - indexed for MEDLINE]


Causal Effects of Metabolic Factors on Pancreatic Ductal Adenocarcinoma Risk: A Mendelian Randomization Study.
Niger Postgrad Med J
Zhou J, Yu Y, Xia T, Chen C.
PMID: 42390509 [PubMed - indexed for MEDLINE]


Redox Metabolism and Metabolic Vulnerabilities in Diabetes-Driven Pancreatic Cancer: Targeting System Xc(-), mTORC1, and Disulfidptosis as Therapeutic Strategy.
Cell Biochem Funct
Raj FJ, Solomonraj AR, Thangaraj P.
PMID: 42389908 [PubMed - indexed for MEDLINE]


Bioengineering advances in pancreatic cancer organoids for reproducible tumor microenvironment modeling.
iScience
Chen R, Yin B, Zhang Y, Peng J, Guo X, Wu W.
PMID: 42389605 [PubMed]


Peritoneal metastasis in pancreatic cancer: molecular mechanisms, microenvironmental remodeling, and emerging intraperitoneal interventions.
Front Mol Biosci
Chen J, Li K, Zou Y, Yang J, Xing L, Xiao K.
PMID: 42388567 [PubMed]


Obesity-driven extracellular vesicle signaling in cancer: mechanistic insights and clinical implications.
Oncogenesis
Chakrapani LN, Velasquez J, Suresh J, Sridhar SD, Sankaran R, Arivazhagan SP, Shanmugam A, Dorayappan KDP, O'Malley DM, Muthusamy T, Selvendiran K.
PMID: 42386697 [PubMed - as supplied by publisher]


Robotic versus Open Pancreatoduodenectomy (PORTAL): multicentre, single masked, phase 3, non-inferiority randomised controlled trial.
BMJ
Jin J, Qin K, Gemenetzis G, Wang Z, Zheng C, Li W, Wu Z, Shi Y, Chen M, Qian J, Weng Y, Chen W, Jin W, Jin R, Li J, Liu L, Chen Y, Han B, Liang X, Sun C, Wu Z, Mou Y, Yin X, Deng X, Peng C, He T, Song Y, Shen B.
PMID: 42386316 [PubMed - indexed for MEDLINE]


NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial.
ESMO Open
Kahl T, Eisenring SD, Liposits G.
PMID: 42385673 [PubMed - as supplied by publisher]


Perioperative tislelizumab for early-stage hepatocellular carcinoma: A phase II trial with integrated tumour microenvironment profiling and predictive modeling.
Drug Resist Updat
Chen L, Han R, Zhai S, Wang Y, Ma X, Cao Z, Li G, Zhang S, Gong W, Hao J, Song T.
PMID: 42385524 [PubMed - as supplied by publisher]


Longitudinal assessment of health-related quality of life in patients with borderline and locally advanced pancreatic cancer undergoing neoadjuvant FOLFIRINOX chemotherapy: results from a prospective multicenter trial.
Langenbecks Arch Surg
de Carvalho LFA, Ceelen W, Meertens A, Rashidian N, Waked B, Geboes K, Ribeiro S, Gorleer K, Dedecker H, Triest L, Vervaecke A, Sas S, Sierens B, Beyls C, Sie M, van Dijk M, Verhaeghe N, Berrevoet F.
PMID: 42384236 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 60719    Page 1 of 3036  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1